According to a report by Scoop Media on October 16, the Asia Pacific Association for Nicotine and Tobacco Harm Reduction Advocacy (CAPHRA) has issued a warning to the New Zealand government delegation attending the tenth session of the World Health Organization Framework Convention on Tobacco Control (FCTC COP10).
Government officials need to realize that their support for FCTC COP10 resolution could have a negative impact on the future of safer nicotine products, according to Nancy Loucas, the coordinator of CAPHRA, an advocate for harm reduction and public health policy expert.
Ms. Lucas stated, "The analysis by GSTHR confirms the significance of these decisions for the future of these products, but during the meeting, they were completely ignored." The publicly available briefing, titled "FCTC COP10 Agenda and Related Documents: The Impact on Tobacco Harm Reduction," reveals that safer nicotine products are seen as a threat to tobacco control rather than as tools to support smoking cessation and reduce high-risk tobacco use.
Mrs. Lucas stated that the development of safer nicotine products could potentially change the rules of the game in combating tobacco-related harm. However, the current narrative of FCTC COP10 does not reflect this possibility. Instead, they are perceived as a threat that could have serious implications for public health.
CAPHRA is urging the government and policymakers to consider the evidence presented in this briefing and recognize the potential of safer nicotine products as tools for harm reduction. "The decisions made at the FCTC COP10 conference will shape the future of tobacco harm reduction," added Ms. Lucas. "We urge all stakeholders to consider the evidence and make decisions prioritizing public health and harm reduction – the lives of consumers are at stake.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
